0 Novel antifungal presents opportunities for treating aspergillosis
Researchers have uncovered the pharmacodynamic properties of novel antifungal, F901318, taking it one step closer to testing in clinical trials
Browsing: Fungal > Aspergillosis
0 Understanding molecular causes of antifungal resistance in A. fumigatus
In this piece, Fabio Gsaller discusses the mechanisms underpinning antifungal resistance in A. fumigatus and his work on the use of 5-flucytosine as a therapeutic agent in managing aspergillosis.
0 From Aspergillus to antifungal resistance – an interview with Cornelia Lass-Flörl
In this interview, we speak to Cornelia Lass-Flörl from the Innsbruck Medical University (Austria) who has a special interest in the epidemiology, diagnosis, prevention and therapy of fungal infections.
0 Infographic: Fungal infections – the hidden burden
Take a look at our infographic to find out more about the burden of some common fungal infections and assess why the facts and figures are so uncertain.
0 Invasive Aspergillosis in the Intensive Care Unit
In this feature, ID Hub discusses the risk factors contributing to invasive Aspergillosis susceptibility, in addition to the obstacles facing diagnosis and therapy in the Intensive Care Unit.
0 Galactofuranose antigens, a target for diagnosis of fungal infections in humans
The use of biomarkers for the detection of fungal infections is of interest to complement histopathological and culture methods. Could chemically synthesized Galactofuranose antigens, reviewed in this paper, be used for the synthesis of artificial carbohydrate-based antigens and in diagnosis?
0 Diagnostics and susceptibility testing in Aspergillus
This review delves into new diagnostic Aspergillus spp. procedures, in addition, the authors look at intrinsic antifungal resistance and mechanisms of secondary resistance to triazoles in A. fumigatus.